Prof. Dr. Andreas Plückthun

 

Member of the Board of Directors

Prof. Dr. Andreas Plückthun is Full Professor at the Department of Biochemistry at the University of Zurich and a co-founder of Molecular Partners (2004), the German biotechnology company MorphoSys, a leading antibody company (1992), and G7 Therapeutics (2014), a GPCR company, successfully divested to Heptares in 2016. Dr. Plückthun was appointed to the faculty of the University of Zurich as a Full Professor of Biochemistry in 1993. Dr. Plückthun was group leader at the Genzentrum and Max-Planck-Institut für Biochemie in Martinsried, Germany (1985-1993). His pioneering scientific work has made him one of the most highly cited scientists in the protein science field and his work has been honored by a number of international awards. Dr. Plückthun studied chemistry at the University of Heidelberg and received his graduate education at the University of California San Diego, where he obtained a PhD in 1982 in the group of Prof. Edward Dennis. He also worked as a postdoctoral fellow in the Chemistry Department of Harvard University (1982-1985).